Transplant Trial Watch
Transplant International · 2024
DOI: 10.3389/ti.2024.13111 ↗Kurz gefasst
Editorial in der Zeitschrift Transplant International, 2024. Verfasst von Simon R Knight und 1 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Transplant Centre, Churchill Hospital, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Immunosuppressive Agents. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To keep the transplantation community informed about recently published level 1 evidence in organ transplantation ESOT and the Centre for Evidence in Transplantation have developed the Transplant Trial Watch. The Transplant Trial Watch is a monthly overview of 10 new randomised controlled trials (RCTs) and systematic reviews. This page of Transplant International offers commentaries on methodological issues and clinical implications on two articles of particular interest from the CET Transplant Trial Watch monthly selection. For all high quality evidence in solid organ transplantation, visit the Transplant Library: www.transplantlibrary.com
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oxford Transplant Centre, Churchill Hospital, Oxford, United Kingdom.
- Centre for Evidence in Transplantation, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
- University Hospitals Coventry and Warwickshire, Coventry, United Kingdom.
Zitieren
APA
Knight, S. R., & O'Callaghan, J. M. (2024). Transplant Trial Watch. Transplant International. https://doi.org/10.3389/ti.2024.13111
Vancouver
Knight SR, O'Callaghan JM. Transplant Trial Watch. Transplant International. 2024. doi:10.3389/ti.2024.13111
BibTeX
@article{Knight2024,
author = {Knight, Simon R and O'Callaghan, John M},
title = {Transplant Trial Watch},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.13111}
}
EUVIMED